Introduction
Ovarian carcinosarcoma (OCS), also known as müllerian mixed tumor or mesodermal mixed tumor, is a rare but aggressive malignancy histologically composed of carcinomatous and sarcomatous elements. 1 Previous studies have shown that an older age at onset, higher International Federation of Gynecology and Obstetrics (FIGO) stage, and worse prognosis are observed in women with OCS when compared to women with epithelial ovarian carcinoma (EOC). 2, 3 Given the rarity of OCS, it is difficult to carry out prospective clinical trials with this disease. Therefore, the mainstay of treatment for OCS is primarily based on management experience of EOC and data from retrospective
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Wang et al studies including a small number of cases. [4] [5] [6] [7] [8] [9] To date there is no uniform agreement about the optimal management of OCS. Previous series of studies have observed that there is survival benefit for women with OCS who undergo cytoreductive surgery followed by platinum-based chemotherapy. [4] [5] [6] [7] [8] [9] Therefore, debulking surgery combined with chemotherapy is the preferred treatment for OCS.
The Surveillance, Epidemiology, and End Results (SEER) database, covering approximately 28% of the population of the USA, collects data on cancer cases from different districts and sources. Rauh-Hain et al summarized OCS data in the SEER database and found that OCS women with lymph node dissection (LND) had a lower lymph node metastasis (LNM) rate than women with high grade serous ovarian carcinoma (HGSOC) women with LND. 2 Garg et al compared OCS survival rates with those of uterine carcinosarcoma (UCS) by analyzing the SEER database and showed that LND was significantly associated with an improved OCS and UCS survival. 10 However, a multi-center study by the Taiwanese Gynecologic Oncology Group found that pelvic LNM for carcinosarcoma of the ovary, fallopian tube, and peritoneum trended toward worse survival without statistical significance. 11 The condition of LNM in early OCS, its relationship with prognosis, and whether LND is necessary in early OCS have not been previously reported. The purpose of this study is to explore the prognostic effect of lymphatic metastasis and resection in early OCS based on a large sample from SEER.
Patients and methods Patients
OCS data were collected from the SEER database, consisting of 18 population-based cancer registries. Clinicopathological information was extracted using the "case listing" option of the SEER*Stat 8.3.4 software. Preliminary selection criteria for study cases included: 1) diagnosis of OCS or müllerian mixed tumor or mesodermal mixed tumor; 2) histological confirmation of disease; 3) diagnosis between 1988 and 2010. A total of 2,275 patients with OCS met our inclusion criteria. Exclusion criteria were: 1) multiple primary malignancies; 2) non-American Joint Committee on Cancer (AJCC) T1 and T2; 3) distant metastasis; 4) unknown regional lymph nodes examination; 5) unknown survival time; 6) no surgery performed. Finally, 363 patients with early OCS were identified ( Figure 1 
Statistical analysis
Frequency distribution of clinicopathological variables between LND (+) and LND (−) groups was compared with the χ 2 test and the Fisher exact test. The Mann-Whitney test was used to compare the mean age of the two groups. The LNM rate of different AJCC T categories was calculated as the number of patients with LNM divided by patients with lymphadenectomy in each AJCC T category. Survival curves were generated using the Kaplan-Meier method. Univariate and multivariate analyses of the effects of categorical variables on the survival were performed using Cox proportional hazards model. Multivariate Cox regression analysis was used to identify independent prognostic factors for all cases (n = 363) and cases who underwent lymphadenectomy (n = 186). In LND (+) group, the LNM rate of patients with AJCC T1 was 9.6%. Contrastingly, 16.3% patients had LNM in AJCC T2 (Table 2) .
Multivariate Cox regression analysis in patients with OCS showed that LND (p = 0.042) and early AJCC T categories (p < 0.001) were positively associated with cancer-specific survival (CSS) after adjusting for age, registry district, tumor laterality, AJCC T categories, and LND. These adjusted variables had statistically significant differences in univariate 
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Wang et al analysis of CSS. Lymphadenectomy (p = 0.031), early AJCC T categories (p < 0.001), and age ≤ 63 (p < 0.001) were associated with an improved overall survival (OS) in multivariate analysis after adjusting for age, registry district, AJCC T categories, and LND that influenced OS in univariate analysis (Table 3) . In Kaplan-Meier survival analysis stratified by AJCC T categories, we found that a higher survival benefit was observed in LND (+) group than LND (−) group in AJCC T2 (p = 0.006 for CSS, p = 0.002 for OS; Figure 2C and D), but there was no statistically significant difference between LND (+) group and LND (−) group in AJCC T1 (p = 0.887 for CSS, p = 0.582 for OS; Figure 2A and B).
Multivariate analysis of LND (+) group showed that LNM (p = 0.001 for CSS, p = 0.004 for OS) and AJCC T categories (p < 0.001 for CSS, p = 0.002 for OS) were independent prognostic factors of patients. Older age was negatively associated with OS (p = 0.042); it was not confirmed to be related with CSS (p = 0.187; Table 4 ).
In LND (+) group, the subgroup analysis by AJCC T categories revealed that patients with LNM had lower CSS (p = 0.004; Figure 3C ) and OS (p = 0.003; Figure 3D ) rate than patients without LNM in AJCC T2. No survival difference was found between LNM (+) group and LNM (-) group in AJCC T1 (p = 0.377 for CSS, p = 0.257 for OS; Figure 3A and B). Figure 4A and B shows the survival differences of various AJCC T categories combined with various AJCC N categories in LND (+) group. Any two comparisons of four groups by Log-rank method showed that patients with AJCC T2N1M0 had a poorer survival outcome than patients with AJCC T2N0M0 (p = 0.006 for CSS, p = 0.005 for OS), T1N1M0 (p = 0.034 for CSS, p =0.043 for OS) and T1N0M0 (p < 0.001 for CSS, p < 0.001 for OS). However, there was no statistically significant survival difference between patients with AJCC T1N1M0 and patients with AJCC T1N0M0 (p = 0.377 for CSS, p = 0.257 for OS; Table S1 ).
Discussion
OCS consists of malignant epithelial and stromal components that accounts for 1% to 4% of all EOC. 1, 12 Previous series of studies have noted that OCS with poor survival outcome has more aggressive tumor biology compared to other histological subsets of EOC. 1, 13, 14 Considering the rarity of OCS, publications on the role that LND plays in the management of OCS are few. Because of this, making full use of large sample databases such as SEER and the National Cancer Database can enable powerful analysis of clinicopathological characteristics and survival outcomes from a greater number of women with OCS. 2 In an analysis of 47 cases with primary OCS, six women (35.3%) had positive lymph nodes among 17 women who underwent LND. 15 Our study used the SEER database to show the prevalence of LNM, and the relationship between survival outcomes and LND as well as LNM when OCS was limited to ovaries (AJCC T1) or confined to the pelvic cavity (AJCC T2).
Complete surgical cytoreduction is significantly associated with improved survival according to small retrospective studies. 4, 6, 16 It is well-known that National Comprehensive Cancer Network guidelines for EOC recommend comprehensive surgical staging be performed in early EOC. However, whether regional lymphadenectomy should be performed in early OCS deserves further investigation. Women with OCS tend to present at an older age when compared to women with EOC. 2, 3, 8 In our study, the mean age at diagnosis of LND (+) group (60.52 years old) was younger than LND (−) group (65.43 years old). This indirectly suggests that surgeons may take a patient's age into consideration when deciding the scope of debulking surgery. Additionally, we found that more patients with OCS between 2001 and 2010 received 3 Our study showed that the LNM rate of OCS was 9.6% in AJCC T1 and 16.3% in AJCC T2. Research on early OCS is few owing to its rarity. To our knowledge, there is no literature reporting on LNM in early OCS. We made a comparison between OCS and UCS in terms of LNM prevalence. A previous study demonstrated that 16 .7% (34/203) of patients with early UCS had retroperitoneal LNM; it was similar to the LNM prevalence of OCS in AJCC T2. 17 Jernigan et al showed that age, stage, and complete surgical cytoreduction were independent prognostic variables in a study of 47 women with OCS. 6 In our study, multivariate analysis identified an independent positive association of early AJCC T categories and LND with CSS and OS. Older age was negatively associated with OS but not CSS in multivariate analysis. Younger age, early diagnosis, early stage, surgical treatment, and LND were reported to be positively associated with survival outcomes in OCS. 2 We made a survival comparison between LND (+) and LND (−) groups following stratification by AJCC T categories. In subgroup analysis, no survival difference was observed between LND (+) and LND (−) groups in AJCC T1 (CSS, HR = 0.96, 95% CI = 0.56-1.65; OS, HR = 0.88, 95% CI = 0.56-1.38). 
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Impact of LNM and LND on survival in early OCS advanced AJCC T categories were significantly associated with a worse CSS and OS. Gynecologic Cancer InterGroup provided a consensus review for OCS and UCS. Women with OCS and UCS have a worse survival rate with a high risk of recurrence compared to those with endometrioid or highgrade serous histologies. Complete surgical staging combined with chemotherapy is recommended for patients with OCS or UCS regardless of early or advanced stage disease. 18 To date no research has clearly shown the relationship between LNM and the prognosis of OCS. However, a study published by Şükür et al. demonstrated that LNM was the most important predictor of UCS survival in a multivariate analysis. 19 The Cox model identified an independent negative association between older age and OS but not CSS, which suggests that the elderly with OCS may die of other diseases or causes # Number of patients; *no information concerning laterality; one case with "paired" was not included in univariate analysis. Abbreviations: OCS, ovarian carcinosarcoma; CSS, cancer-specific survival; OS, overall survival; LND, lymph node dissection; LNM, lymph node metastasis; AJCC, American Joint Committee on Cancer; T, primary tumor; NOS, not otherwise specified; SEER, Surveillance, Epidemiology, and End Results.
rather than OCS. Subgroup analysis revealed that LNM had an impact on CSS and OS in AJCC T2 (CSS, HR = 3.62, 95% CI = 1.50-8.73; OS, HR = 3.71, 95% CI = 1.59-8.68) but not AJCC T1 (CSS, HR = 1.78, 95% CI = 0.50-6.37; OS, HR = 1.97, 95% CI = 0.61-6.39).
As we all know, gynecologic oncologists define tumor staging by FIGO staging. Because of the rarity of OCS cases, OCS staging mainly refers to epithelial ovarian cancer FIGO staging. At presentation, regional LNM in early OCS is classified as FIGO stage IIIa, but we found that patients with AJCC T1N1M0 had a better prognosis when compared to patients with AJCC T2N1M0. Meanwhile, there was no significant difference seen between the survival of patients with AJCC T1N1M0 and AJCC T1N0M0, while a worse survival trend was observed in AJCC T1N1M0 when compared to AJCC 
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Impact of LNM and LND on survival in early OCS T1N0M0. These results may be related to inadequate cases with LNM in AJCC T1. In addition, some unknown factors may have influenced these results, such as whether chemotherapy was used after surgery, chemotherapy regimens, the scope of LND, and so on.
Limitations
Several limitations exist in our study. First, it is possible that there was selection bias in the process of data screening and partial incomplete data because this is a non-randomized retrospective study. Second, there was a lack of central pathological consultation of patients registered in the SEER database. Third, the extent of debulking surgery, scope of lymphadenectomy, and the information regarding chemotherapy use were not available in SEER database while a majority of women with early stage OCS could have received optimal debulking. Finally, the survival outcomes of patients with OCS are also affected by socioeconomic status and environmental exposures.
Conclusion
Our study analyzes LNM prevalence and the role of LND and LNM on survival in early OCS (AJCC T1 and AJCC T2).
Patients with LNM in AJCC T2 were shown to have poor survival outcomes and LND improved the prognosis of patients with AJCC T2. Although there was no demonstration that LND and LNM had an impact on AJCC T1 survival, patients with OCS in AJCC T1 should be considered to undergo LND owe to 9.6% LNM rate. A large-scale multi-center trial may not be feasible because of the rarity of OCS; such a study would have provided further evidence on the role of LND and LND in AJCC T1.
